Antiparkinsonian prescription and extrapyramidal symptoms
نویسندگان
چکیده
منابع مشابه
Fluoxetine Induced Extrapyramidal Symptoms : Case Reports
This case report describes the induction of extrapyramidal symptoms with fluoxetine, which is reported to be a rare phenomenon. A dopamine blockade at the nigrostriatal level primarily mediated by serotonin has been proposed as the probable mechanism.
متن کاملNeuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
The neurological risks and benefits of atypical neuroleptics have received considerable attention in the medical literature, but there have been few controlled studies examining these risks in elderly patients. Well-designed, longterm prospective studies are needed to identify the safest and most effective treatment regimens for elderly patients, but until these studies are complete, clinicians...
متن کاملACUTE EXTRAPYRAMIDAL SYMPTOMS FOLLOWING ABRUPT DISCONTINUATION OF PROPRANOLOL
A case of acute extrapyramidal manifestations consisting of dystonia and akathisia following abrupt discontinuation of propranolol is reported. She responded well to oral propranolol and intramuscular diazepam. Extrapyramidal symptoms have commonly been associated with acute or chronic administration of neuroleptic drugs. There have been reports of a substantial number of cases with simila...
متن کاملDevelopment of extrapyramidal symptoms in hypertensive patients treated with diazoxide.
Extrapyramidal symptoms developed a variable time after the start of treatment with oral diazoxide in 15% of a series of 100 severely hypertensive patients. Six illustrative cases are described. Treatment with diazoxide could be continued in four of these. The symptoms are usually controllable either by dosage adjustment or by the use of diazepam or procyclidine. There was no evidence of irreve...
متن کاملEstablishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.
OBJECTIVE Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 2006
ISSN: 0007-1250,1472-1465
DOI: 10.1192/bjp.188.5.492